ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Novelix Pharmaceuticals reported no deviation in its July 2026 fund raise utilisation for the September quarter. This periodic statement records no new business event.
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹44.7 Cr (+22.8% YoY) and net profit of ₹1.6 Cr (+220.0% YoY) for Q2 FY27.
Novelix Pharmaceuticals has given prior intimation of a board meeting on 11 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until forty-eight hours after the meeting.
Novelix Pharmaceuticals Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Novelix Pharmaceuticals announced the appointment of Mr. Gnana Prakash Gattu as Whole Time Director, approved by shareholders at the company's 32nd Annual General Meeting.
Novelix Pharmaceuticals held its 32nd Annual General Meeting on 30th September, 2026, transacting ordinary and special business items via e-voting and video conferencing.
Novelix Pharmaceuticals informs shareholders that the Annual Report for FY 2025-26 and the 32nd AGM notice are available on the Company's website.
Novelix Pharmaceuticals filed its Annual Report and AGM Notice for the financial year 2025-26. The 32nd Annual General Meeting is scheduled for September 30, 2026.
Novelix Pharmaceuticals Limited will hold its 32nd Annual General Meeting on September 30, 2026. The company has fixed September 23, 2026, as the cut-off date for e-voting.
Novelix Pharmaceuticals Limited appointed Mr. Gnana Prakash Gattu as Whole-time Director for a five-year term. The appointment, effective August 29, 2026, awaits shareholder approval.
Novelix Pharmaceuticals Ltd approved the AGM notice and appointed Mr. Gnana Prakash Gattu as a Whole-time Director in its board meeting outcome.
Novelix Pharmaceuticals Limited will hold a board meeting on August 29, 2026, to discuss the AGM notice, annual report, and a director appointment.
Novelix Pharmaceuticals executed a five-year land lease for micro algae cultivation in Telangana. The company will pay a monthly rent of Rs. 5,000 for 0.925 acres.
Novelix Pharmaceuticals filed its Statement of Deviation and Variation for the quarter ended June 30, 2026, reporting no deviations in fund utilization.
Novelix Pharmaceuticals Ltd reported revenue from operations of ₹36.9 Cr (+64.7% YoY) and net profit of ₹1.2 Cr (+1100.0% YoY) for Q1 FY27.